A team of Australian researchers have identified a biochemical marker in the blood that may be used to identify
A team of Australian researchers have identified a biochemical marker in the blood that may be used to identify
newborn babies at risk for sudden infant death syndrome (SIDS),
which could open the way to future interventions that could prevent tragedies.
Researchers found that SIDS victims had lower levels of an enzyme known as butyrylcholinesterase (BChE) shortly after birth.
A low level of BChE would cause a sleeping infant to have a difficult
time waking up or responding to its surroundings.
Dr. Carmel Harrington of The Children's Hospital at Westmead in
Australia said in a statement that the research offers hope for the future but also answers for the past.